Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Prepaid Assets (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Prepaid Assets for 4 consecutive years, with $274000.0 as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 3.01% to $274000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $274000.0 through Dec 2025, up 3.01% year-over-year, with the annual reading at $274000.0 for FY2025, 3.01% up from the prior year.
  • Prepaid Assets for Q4 2025 was $274000.0 at Century Therapeutics, down from $5.0 million in the prior quarter.
  • The five-year high for Prepaid Assets was $7.9 million in Q3 2024, with the low at $46000.0 in Q3 2023.
  • Average Prepaid Assets over 4 years is $3.6 million, with a median of $4.3 million recorded in 2023.
  • The sharpest move saw Prepaid Assets plummeted 99.15% in 2023, then skyrocketed 17067.39% in 2024.
  • Over 4 years, Prepaid Assets stood at $4.0 million in 2022, then increased by 6.32% to $4.3 million in 2023, then plummeted by 93.75% to $266000.0 in 2024, then increased by 3.01% to $274000.0 in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $274000.0, $5.0 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.